Dr. Matthew Galsky, M.D.
Claim this profileMount Sinai Medical Center
Studies Bladder Cancer
Studies Cancer
15 reported clinical trials
28 drugs studied
Area of expertise
1Bladder Cancer
Stage III
Stage IV
HER2 positive
2Cancer
Stage III
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Matthew Galsky, M.D. is currently running
FX-909
for Bladder Cancer
This trial tests a new tablet called FX-909 for safety and proper dosage in patients with advanced solid tumors, especially advanced urothelial carcinoma. Doctors will closely monitor patients to understand how the drug works and its effects on the body and tumors.
Recruiting1 award Phase 1
CC-94676
for Metastatic Castration-Resistant Prostate Cancer
This trial is testing a new drug called CC-94676 to see if it is safe and effective for men with advanced prostate cancer that continues to grow despite hormone-lowering treatments.
Recruiting1 award Phase 1
More about Matthew Galsky, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Matthew Galsky, M.D. has experience with
- Nivolumab
- Pembrolizumab
- Carboplatin
- Ipilimumab
- Cisplatin
- Gemcitabine
Breakdown of trials Matthew Galsky, M.D. has run
Bladder Cancer
Cancer
Prostate Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Galsky, M.D. specialize in?
Matthew Galsky, M.D. focuses on Bladder Cancer and Cancer. In particular, much of their work with Bladder Cancer has involved Stage III patients, or patients who are Stage IV.
Is Matthew Galsky, M.D. currently recruiting for clinical trials?
Yes, Matthew Galsky, M.D. is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Matthew Galsky, M.D. has studied deeply?
Yes, Matthew Galsky, M.D. has studied treatments such as Nivolumab, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Matthew Galsky, M.D.?
Apply for one of the trials that Matthew Galsky, M.D. is conducting.
What is the office address of Matthew Galsky, M.D.?
The office of Matthew Galsky, M.D. is located at: Mount Sinai Medical Center, New York, New York 10029 United States. This is the address for their practice at the Mount Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.